qordata
  • Products
    • Reporting
    • Transparency Reporting Solution
    • Monitoring
    • Compliance Central
    • Expense Monitoring & Auditing Solution (EMA)
    • Process
    • EngageAgent
    • Grants & Sponsorship Management Solution
  • Thought Leadership
    • Surveys and Insights
    • Whitepapers
    • Case Studies
    • Webinars
  • Company
    • About Us
    • Leadership Team
    • Our Partners
    • Contact Us
Schedule a Demo
Reporting Transparency Reporting Solution Monitoring Compliance Central Expense Monitoring & Auditing Solution (EMA) Process EngageAgent Grants & Sponsorship Management Solution
Surveys and Insights Whitepapers Case Studies Webinars
About Us Leadership Team Our Partners Contact Us
Schedule a Demo

Blogs

Expert insights, compliance best practices, and industry analysis from the qordata team to help life sciences professionals stay ahead.

Data Driven Compliance
List of Commercial Compliance Policies and Procedures You Should Develop
Life sciences compliance is under intense pressure to be more effective and meet rising board and regulatory expectations. Maintaining comme...
Compliance Data Analytics
Why Rising Healthcare Fraud Penalties Make It Important for Companies To Know Their Data
The civil monetary penalties for violations of healthcare laws and regulations are on the rise. A few months back, we discussed the sharp in...
Data Driven Compliance
The Priority of Data Scrutiny in Compliance 2025
Accidental discoveries often change the course of history. Take Alexander Fleming’s observation of penicillin, for example. However, in life...
Aggregate Spend Reporting
Minimizing Risks: A Guide to Ethical HCP Engagement
Ethical HCP engagement has become a crucial component of ensuring compliance and transparency in the interaction between healthcare professi...
Aggregate Spend Reporting
The Facts About Open Payments Data in 2024
In the reporting year 2023, life sciences companies reported 15.64 million records totaling $12.75 billion in general and resear...
Aggregate Spend Reporting
5 Key Qualities of a Transparency Reporting Partner You Should Look For in 2025 
With regulations such as the U.S. Physician Payments Sunshine Act (Sunshine Act) mandating the disclosure of financial relationships with ...
Life Sciences Compliance
The Life Sciences Industry’s Regulatory Outlook in 2025
As we step into 2025 , life sciences companies continue to push the boundaries of breakthrough innovations that improve patient healt...
Aggregate Spend Reporting
Transparency Reporting in Life Sciences: Unifying Efforts Across Core Areas
Transparency reporting in life sciences is both a regulatory requirement and a crucial factor in maintaining trust within the life sciences,...
Artificial Intelligence
Top 7 Key Areas of Focus for Effective Compliance Risk Analytics
A New Paradigm in Detecting and Addressing Risks
Compliance Data Analytics
Pharma Data Analytics for Life Sciences Compliance in 2025
As the pharmaceutical industry evolves in 2025, leveraging Pharma Data Analytics has become imperative for achieving compliance, operational...
Life Sciences Compliance
Top 7 Considerations for Life Sciences Compliance
Life sciences compliance and risk professionals face the dual challenge of keeping pace with evolving regulations and leveraging advanced te...
Compliance Data Analytics
How AI-Powered Risk Analytics Take Compliance from Reactive to Preventive
Compliance officers are overwhelmed by risks arising from global regulations and enterprise-wide commercial activities. With evolving regul...
Compliance Data Analytics
The Role of Data Analytics in Life Sciences Compliance 2025
The life sciences industry faces a rapidly evolving regulatory landscape, with increasing scrutiny on transparency and compliance. Navigatin...
Compliance Monitoring
How to Implement Compliance Monitoring Workflow in 2025?
With 2025 approaching, it's time to re-evaluate and optimize your compliance monitoring workflows to stay ahead of the curve. The Complianc...
Expense Monitoring & Auditing
Leveraging Transaction Monitoring Software for Success in Life Sciences
The intricate landscape of regulations in the U.S. calls for effective tools to monitor, document, and ensure compliance across all transact...
Expense Monitoring & Auditing
Life Sciences Compliance - Risk Remediation vs. Risk Mitigation
Compliance professionals in the U.S. must navigate a complex landscape of regulations, including those set forth by the Department of Health...
Compliance Monitoring
Effective Compliance Risk Assessment in Life Sciences - Key Components
In the life sciences industry, maintaining compliance with an evolving regulatory environment is crucial to ensuring patient safety, data in...
Compliance Monitoring
Best Practices for Compliance Remediation in the Life Sciences Industry
“Effective remediation relies on companies to fully understand and contextualize the observations made during an inspection and address root...
Expense Monitoring & Auditing
The 6 Important Criteria for Comparing Expense Management Software
qordata complies with ISO 27001 and SOC Type 2 standards, enabling us to ensure robust security for your organization’s compliance or expens...
HCP Engagement
Top 5 Essential Pharma HCP Engagement Rules in Life Sciences
What Is Pharma HCP Engagement? Why Does It Matter in Life Sciences? HCP engagement is one of the most critical aspects of the life science...
Compliance Monitoring
5 Must-Have Features to Conduct Effective HCP Debarment Screening
Effective HCP (Healthcare Professional) debarment screening is the backbone of compliance and risk management. As regulatory landscapes cont...
Artificial Intelligence
Real-Time T&E Monitoring: How Technology is Revolutionizing Compliance?
A high degree of fraud often occurs in the T&E area, making it a critical starting point for identifying non-compliance. However, condu...
Expense Monitoring & Auditing
How To Manage Expense Reporting Fraud Within Life Sciences? 
Expense report fraud is a big problem, especially in the life sciences industry where following rules and regulations is quite important. Fr...
Expense Monitoring & Auditing
A Comprehensive Guide to Auditing Expense Reports for Life Sciences Companies
Organizations lose an estimated 5% of all revenue to fraud each year. According to the Association of Certified Fraud Examiners (ACFE), this...
Data Driven Compliance
The Importance of Data-Driven Compliance in the Life Sciences Industry
The life sciences industry in the United States is a complex and heavily regulated sector. With the critical nature of its work, ensuring co...
CMS
Understanding the Financial Thresholds in CMS Open Payments Data 2024
The CMS Open Payments Program requires life sciences companies to report payments and transfers of value to physicians, teaching hospitals, ...
HCP Engagement
Compliance Essentials: Data-Driven HCP Engagements
In the U.S. Life Sciences sector, managing interactions with Healthcare Professionals (HCPs) and Healthcare Organizations (HCOs) is critical...
Artificial Intelligence
Enhancing Commercial Compliance Operations Through AI-Driven Solutions
The life sciences industry is subject to stringent regulatory requirements and constant scrutiny, making compliance a critical yet challengi...
CMS
7 Ways AI Chatbot Transform CMS Open Payments Data into Actionable Intelligence
The new era of regulatory enforcement demands companies and compliance teams to stay ahead of the curve by leveraging cutting-edge AI techn...
Data Driven Compliance
Contextual Analytics: The Foundation of a Data-Driven Compliance Program
“ 48% of compliance teams are turning to big data and analytics to strengthen their compliance function.”
Compliance Monitoring
Commercial Compliance Programs: Everything You Need to Know
Commercial compliance programs serve as the foundation of organizational integrity, ensuring adherence to all applicable rules and regulatio...
Artificial Intelligence
Using Artificial Intelligence To Manage Life Sciences Compliance
In the life sciences industry , ensuring regulatory compliance and effectively managing risks associated with healthcare professional (HCP)...
Data Driven Compliance
Overview of the OIG's General Compliance Program Guidance 2023
The U.S Department of Health and Human Services (HHS) Office of Inspector General (OIG) issued the General Compliance Program Guidance (GCP...
Expense Monitoring & Auditing
Leveraging Automated Expense Monitoring & Auditing for Compliance
Newly appointed compliance professionals cannot be expected to understand the hassle of manually auditing 100% of commercial expense data....
HCP Engagement
The 7 Steps to Ensure Compliant Healthcare Professionals (HCP) Engagements
"Total penalties from compliance-related violations have crossed over $20 Billion since 2000 ." Ethical and law-compliant interaction betw...
Aeons
Aeons Echo Cheat Engine Latest Version Download — Free 2026
Reviewed: April 2026 — Content confirmed accurate
Life Sciences Compliance
5 Best Ways for Compliance Officers to Successfully Manage Commercial Compliance
Regulatory expectations and board scrutiny are increasing, and there's also a growing pressure on compliance leaders to oversee a wider ra...
Topaz
How to Download Topaz Sharpen Ai Free — Full Guide 2026
Last Verified: May 2026 — Tested on latest version
CMS
6 Steps to Increase the Effectiveness of Your CMS Open Payments Reporting Program
“Failure to report complete and accurate CMS Open Payments data on time can result in Penalties and Fines of up to $1,150,000.” What is C...
Aggregate Spend Reporting
Open Payments Reporting: Frequently Asked Questions (FAQs) for Compliance Officers
CMS Open Payments reporting stands out as a critical aspect of life sciences compliance that demands meticulous attention from compliance of...
Compliance Monitoring
2025 Compliance Roadmap: Strategic Monitoring Planning for Leaders
Monitoring compliance has become an imperative for life sciences companies. Considering that total penalties from compliance-related violati...
Data Driven Compliance
A Roadmap for New Chief Compliance Officers: 10 Essential Steps
“The CCO has a critical role in today’s complex business environment. They play a vital role in protecting the organization from reputationa...
Compliance Monitoring
Continuous Improvement Is The Leading Success Indicator for Compliance Programs: Here's Why?
Life sciences companies have been one of the most regulated industries over the past 10 to 15 years, with a significant number of regulatory...
Compliance Monitoring
How to Leverage Data to Monitor Regulatory Compliance in Your Organization
In today’s intricate regulatory environment, compliance isn’t just a requirement—it’s a dynamic challenge that demands a data-driven compli...
Compliance Monitoring
Top 5 Compliance Priorities for CCOs in 2025
Chief Compliance Officers (CCOs) play a vital role in ensuring that organizations operate within the bounds of the law and adhere to regulat...
Compliance Monitoring
Why New Regulatory Demands Require an Advanced Approach to Compliance
Regulatory demands for life sciences companies have evolved significantly over the years. In the past, regulations were primarily focused on...
Aggregate Spend Reporting
Review Data Collection Processes for Compliant Spend Reporting
As the Life Sciences industry evolves, the significance of robust data collection processes cannot be overstated, especially when submitting...
Compliance Data Analytics
8 Ways to Ensure Compliance Success with Analytics
The importance of adhering to regulatory demands continues an upward trend. Life science compliance is becoming more complex with heightened...
Compliance Data Analytics
How Data and Technology is Transforming the Role of Compliance Professionals
Life sciences companies continue introducing novel therapies, treatments, and new scientific discoveries, such as Abbvie’s hepatitis C treat...
Compliance Monitoring
How To Handle Government Investigations: Showcasing Audit Readiness
73% [1]  of compliance officers indicate "increasing regulatory expectations" and "scrutiny with boards/regulators" as the top two sources...
Compliance Monitoring
Data & Compliance: What You Know Can Empower You
Let's start with the DOJ's updated compliance guidance  for life sciences companies. They put forward clear expectations related to comp...
Compliance Monitoring
How Digitalized Compliance Monitoring of Speaker Programs Ensures Effective Adherence to Anti-Kickback Statute
Life sciences companies rely on speaker programs to educate healthcare professionals (HCPs) about their products and services. However, thes...
Compliance Monitoring
Detecting & Preventing Kickbacks to HCPs Using Compliance Monitoring
According to a study by the Office of the Inspector General (OIG), from 2016 to 2020, 13% of all Anti-Kickback Statute (AKS) enforcement a...
Compliance Data Analytics
7 Tips for Starting Your Life Sciences Compliance Analytics Program
Proactive life sciences companies leverage data analytics to analyze their compliance data, derive insights, and arrive at accurate conclu...
False Claims Act
4 Things to Know About the False Claims Act (FCA)
The False Claims Act, often referred to as the "Lincoln Law," finds its roots in a critical period of American history – the Civil War – w...
CMS
5 Advantages of Comparing Your Spend Data With The Life Sciences Industry’s Data
Do the Key Opinion Leaders and researchers you pay also receive payments from other manufacturers?
Compliance Data Analytics
Utilizing Data Visualization To Enhance Life Sciences Compliance
Regulatory Diversification : Different regions have unique regulatory frameworks, making it crucial to comprehend and comply with each juris...
Aggregate Spend Reporting
Conflicts of Interest and CMS Open Payments: Safeguarding Transparency in the Life Sciences Industry
Financial Gains : Healthcare providers may receive payments, gifts, or other compensation from pharmaceutical companies or manufacturers. Th...
Compliance Monitoring
Guide To Conducting Compliance Gap Assessment To Improve Regulatory Compliance
Ad-hoc or Incomplete Compliance Programs: These lack formalization and essential capabilities to address critical risks efficiently.
Data Driven Compliance
The Evolving Role of Compliance Officers in the Life Sciences Industry
Complex and Frequent Regulatory Changes: Government agencies frequently release updated guidelines and requirements. Compliance officers mu...
CMS
A Step-By-Step Guide to Solving Open Payments Disputes
User must be registered in the Centers for Medicare & Medicaid Services (CMS) Identify Management System and should have obtained access...
Life Sciences Compliance
The 7 Elements of An Effective Compliance Program
The 7 Elements of An Effective Compliance Program
Aggregate Spend Reporting
The Facts About Open Payments Data in 2023
The publicly accessible information about the payments and transfers of value (ToV) made by reporting entities to covered recipients is know...
Data Driven Compliance
The Importance of Compliance In The Pharmaceutical Industry
Navigating the Shifting Tides of Pharmaceutical Compliance: Embracing Change for a Data-Driven Future
CMS
Natures of Payment: Payments Categories Explained
For compliance professionals working in life sciences companies, a comprehensive understanding of the diverse payment categories, financial ...
Aggregate Spend Reporting
8 Best Practices To Ensure Compliance with Open Payments Sunshine Act
The Physician Payments Sunshine Act requires life sciences companies to report any payments or other transfers of value made to physicians...
Compliance Monitoring
The Importance of Risk Mitigation in the Life Sciences Industry
Life sciences risk monitoring is a critical component of ensuring compliance and operational integrity in a highly regulated industry. Life ...
US Sunshine Act
Sunshine Act Reporting/Transparency Reporting: Explained
Before delving into the mechanics of Sunshine Act reporting, it is useful to reflect on the history and rationale behind this significant pi...
Compliance Monitoring
Reducing Critical Risks Through Data-Driven Compliance Monitoring
Compliance monitoring is a critical aspect of the life sciences industry that enables companies to determine whether they're efficiently a...
Expense Monitoring & Auditing
The Latest Trends in Expense Monitoring & Auditing in 2025
Life Sciences companies face significant challenges ensuring accuracy and transparency in expense monitoring and auditing. To address these ...
HCP Engagement
Data-Driven HCP Engagement Strategies for Life Sciences Companies in 2025
In the pharmaceutical industry, maintaining compliance with the laws and regulations is paramount. The Anti-kickback (AKS) Law prohibits the...
False Claims Act
$100K False Claims Act settlement After Company Violates Anti-Kickback Statute
Earlier this month, the U.S. Attorney’s Office for the District of Massachusetts announced a $100,000 FCA settlement.
Compliance Data Analytics
Is Adaptability Really an Underrated Compliance Skill? Let’s Find Out
Adaptability, in the fewest possible words, is the degree to which an organism adapts to a change in the environment, and this evolution con...
HCP Engagement
Unlock Success in Speaker Programs with Data-Driven Compliance
With heightened scrutiny on speaker events, it is imperative for Life Sciences companies to leverage a data-driven approach to optimize spea...
Data Driven Compliance
Building A Dynamic Compliance Program? Here Are A Few Key Considerations For You
Building an effective and efficient compliance program for Life Sciences companies requires more than in-depth insights into compliance oper...
Life Sciences Compliance
Life Sciences Compliance Made Simpler: Compliance at Its Core
When you take a deep dive into compliance to identify what makes compliance complex, you discover that among siloed processes, dispersed dat...
Aggregate Spend Reporting
U.S. Transparency Reporting: The Newly Added Covered Recipients
Open Payments requirement will now include five other additional provider types. Here are the entities that will be reported from 2022 onwar...
DOJ
Ask Yourself These Five Questions from The DOJ’s Standpoint
According to Maame Ewusi-Mensah Frimpong , the deputy assistant attorney general at the US Department of Justice (DOJ), compliance has be...
Data Driven Compliance
Taking the Transformative Route to Improve Compliance
Changes in the rules and regulations enacted by the government happen to be one of the most disruptive trends Life Sciences and Pharmaceutic...
HCP Engagement
Reducing Compliance Risk with qordata's Data-Driven HCP Engage
Compliant HCP engagements have become imperative for Life Sciences companies. Reducing risk by integrating a data-driven compliance solutio...
Aggregate Spend Reporting
Visualizing Compliance Data: The Power of Integrated Dashboards
Life Sciences is a highly regulated industry , and meeting compliance demands is highly imperative for companies. In addition, the evolving ...
Aggregate Spend Reporting
Analyzing CMS Open Payments Data 2021: Trends and Insights
The Center for Medicare and Medicaid Services (CMS) published data every year, and similarly, they published Open Payments data for the year...
HCP Engagement
Uncovering Key Insights from the OIG’s Special Fraud Alert for Speaker Programs
In November 2020 , the Office of Inspector General (OIG) issued a critical Special Fraud Alert highlighting the key risks associate...
Life Sciences Compliance
Life Sciences Compliance: Shedding Light on Some Recent Settlements
Compliance challenges, evolving rules and regulations, building a data-driven compliance program, and false claims that lead to indictment a...
Data Driven Compliance
Unveiling the Power of Data-Driven Compliance in Life Sciences
The design of a compliance program determines its effectiveness in preventing and detecting compliance risks, i.e., misconduct, breach of in...
Data Driven Compliance
Why a Compliance Program Should Be Data-Driven?
The U.S Department of Justice (DOJ) updated its compliance program evaluation guideline outlining exactly how it evaluates corporate compl...
Data Driven Compliance
Is Managing Compliance Really That Difficult in Life Sciences?
The answer to “ is managing compliance really that difficult?” is that it is and isn’t at the same time. To understand this, we must lo...
Life Sciences Compliance
The Imperativeness of Compliance in Life Sciences
Life sciences and pharmaceuticals operate in a highly regulated industry, and one of the most challenging aspects of operating in this indus...
Compliance Monitoring
Maximizing Value & Insights Through Compliance Monitoring
Monitoring is the ongoing evaluation of business activity taking place, working as intended, and expected outcomes occurring. If your curren...
Compliance Monitoring
The Updated Compliance Monitoring Guide for Life Sciences Companies
Compliance in 2026 is at a crossroads and life sciences companies are facing critical decisions that will shape their future direction in re...
Aggregate Spend Reporting
5 Ways to Meet Aggregate Spend Reporting Deadlines
Meeting the federal and state aggregate spend reporting requirements demands significant time, resources, focus, and strategic processes f...
Data Driven Compliance
The Vital Role of Compliance Partnerships in Life Sciences
New policies, rules, and regulations followed by the dynamic nature of the life sciences industry make it much more overwhelming for complia...
Data Driven Compliance
4 Steps to Enhancing the Effectiveness of a Compliance Program
Mitigating compliance risks is important for life science companies.
Life Sciences Compliance
5 Essential HHS Laws for Life Sciences Companies
A compliance program is an internal system or process composed of a set of rules, regulations, and guidelines created to enable life science...
Life Sciences Compliance
Navigating Compliance Challenges in Life Sciences: Strategies and Solutions
Compliance requirements can be difficult to abide by, but a strategic process consisting of the identification of risks, analysis, and remed...
Data Driven Compliance
Reimagining Compliance Modernization in the Life Sciences Industry
A modernized approach, one that involves the utilization of data analytics, technologies, and automation, to compliance, is the way forward ...
Data Driven Compliance
Revolutionizing Compliance: Top 6 Tech Trends
The life science industry is dynamically changing even as we speak.
Life Sciences Compliance
The Revolution of Data in the Life Sciences Industry
Data is the driving force behind strategic decision-making and various other aspects of the business world. Therefore, recording, maintainin...
Aggregate Spend Reporting
The Fusion of Transparency and Innovation in the Life Sciences Industry
Transparency reporting stands at the forefront of innovation in the life science sector. The evolving compliance requirements demand advan...
Aggregate Spend Reporting
Aggregate Spend Data in the Life Science Industry: An Overview
Data is impacting the modern business landscape from every direction today, and life-science companies are not an exception to the impact.
Aggregate Spend Reporting
Leveraging Aggregate Spend Data in Life Sciences: Uncover Competitive Insights
Annual transparency reports or aggregate spending reporting have become an integral part of life science organizations.
PhRMA Code
Navigating the Key Shift in PhRMA Code
The biggest change to the PhRMA Code is a change that has now been added to Section 2 , which is the section on informational programs with...
Compliance Monitoring
3 Key Strategies for Effective Risk-Based Monitoring
Having a compliance program that ensures 100% adherence to regulations is realistically not possible. But there are monitoring practices t...
PhRMA Code
Quick Review of PhRMA Code Updates and Implications in 2022
As the New Year 2022 begins, a lot of compliance professionals might also be making new year resolutions about being more diligent with th...
Compliance Monitoring
FAQs on PhRMA Code Update: How Does It Apply to Me?
qordata hosted a webinar with Seth Lundy and Brian Bohnenkamp from King & Spalding to keep the compliance community updated with re...
PhRMA Code
PhRMA Code Updates and Implications for Life Sciences Compliance
On August 6, 2021, the Pharmaceutical Research and Manufacturers of America ( PhRMA ) released highly anticipated revisions to its Code on I...
Press Release
qordata Ranks 1351st on 2021 Inc. 5000 List of Fastest-Growing Companies in the US
New Jersey-based compliance solutions and IT consulting services provider qordata has made it to Inc. 5000’s 2021 list as one of the faste...
Aggregate Spend Reporting
Why Open Payments Matters for Life Sciences Companies
The Open Payments program is a transparency program that provides clarity between Pharmaceutical Manufacturers and the payments they make to...
HCP Engagement
Are you prepared for the OIG's Special Fraud Alert for Speaker Programs?
In November 2020, The United States Department of Health and Human Services Office of Inspector General (OIG) issued a " Special Fraud Alert...
HCP Engagement
Insights on OIG Special Fraud Alert for Speaker Programs by Sarah DiFransesca and Leslie Restanio
qordata hosted an interactive webinar with Sarah DiFransesca from Dinsmore & Shohl LLP and Leslie Restanio from Amneal Pharmaceuticals ...
HCP Engagement
HCP Meal Limits Survey 2020 and 2024: Key Findings and Insights
64.7% of companies reported annual revenue under $1 billion, 29.4% between $1 billion and $10 billion, and 5.9% over $10 billion.
HCP Engagement
The Top 5 Compliance Key Risk Indicators in Speaker Programs & HCP Meals
Among the critical components of life sciences compliance, speaker programs and healthcare professional (HCP) meals are two high-risk areas ...
Aggregate Spend Reporting
Sunshine Act Reporting Deadlines for 2024: Federal and State Requirements
The Sunshine Act, a provision of the Affordable Care Act, requires life sciences organizations to report payments and other transfers of val...
Aggregate Spend Reporting
The 4 Most Common Sunshine Act Reporting Mistakes You Should Avoid
As the deadline for CMS Open Payments reports submission draws close, we ought to share 4 of the common mistakes that happen during Federa...
Aggregate Spend Reporting
CMS Open Payments 2020 Changes: What Compliance Professionals Need to Know
About three weeks ago, on November 15th, the compliance industry had another “Oh God, not again!!!” moment. Because CMS had issued changes...
Aggregate Spend Reporting
OIG Reviews Open Payments Data: What Manufacturers and GPOs Need to Know
In case you missed it, OIG recently published a report on its review of Open Payments data published by CMS. A key objective of this review ...
Life Sciences Compliance
Establishing Causality: Physician Spend and Pharma Performance Analysis
Dr. Hu criticism for your company’s engagements, like speaker events or KOL activities
Aggregate Spend Reporting
Penalties for Failure to Report or Erroneous Submissions in Sunshine Payments
Slightly over two months ago, applicable manufacturers in North America added to the 40.74 million records already present in the CMS Open...
Life Sciences Compliance
The Crucial Role of Technology in Achieving GDPR Compliance
“What Role Is Technology Playing In Helping You Become GDPR Compliant ?” We asked this question (or rather, a version of it) during a surve...
Compliance, Privacy, Transparency;
The Evolution of Data Privacy in the EU & USA
Samuel D. Warren and Louis D. Brandeis’ 1890 article “ The Right To Privacy” has become classic reading for 21 st century data professiona...
HCP Engagement
Debating Transparency Beyond Consent Rates - Part II
The approach towards data privacy in the EU makes consideration towards consent revocation an imperative. If a physician revokes consent, i...
HCP Engagement
Debating Physician Consent Rates in Pharma Transparency
Physician consent can be a contentious issue. Especially when data privacy interpretation comes into play. In a webinar we hosted,...
Aggregate Spend Reporting
Pharma Compliance Workflow: 2 Phases | Reporting & Analysis
In qordata’s most recent post: A Quick Quiz To Check Your Compliance Analytics Acumen , Zafar Ahmed quotes Ishita Arora on realistic scope ...
Aggregate Spend Reporting
Here's A Quick Quiz To Check Your Compliance Analytics Acumen
Still unsure about introducing a compliance analytics program into your company? You’re not alone. Of the 9272* medical drug and devi...
Aggregate Spend Reporting
Surprising Figures From CMS Open Payments Data 2016
The pharmaceutical company has also extended this HCP with the highest spend amount in Research this year. One TOV, at $270,250.00, matche...
Aggregate Spend Reporting
qordata Leverages Its Analytics Capabilities To Uncover Critical Insights
The data engineering team at qordata also managed to sift through CMS’ records to find out which drugs drew the highest spend in 2016. L...
Disclosure, EFPIA, Pharma Compliance
Pharma Associations and Transparency in Germany
In our previous post on Dr. Klaus Geltsetzer’s webinar presentation, How to “Determine the Relationships of Different Global Disclosure Req...
Aggregate Spend Reporting
The Impact of Pharma Disclosure on Public Healthcare
The synergy between pharma associations may never materialize. It may even backfire. We will elaborate on this in an upcoming post, with the...
Compliance Data Analytics
Merck USA's Compliance Analytics Journey: A Case Study
How does a member of the Big Pharma Club manage to have a sophisticated Compliance/Transparency Platform? Is the picture complicated while o...
consent management, EFPIA, Hcp master, Pharma Compliance, Physician Engagement
Managing Consent With a Real-Time Database Solution
A major concern for pharma manufacturers in the EU when submitting their spend is that of duplication of data. The reason behind this concer...
Data Driven Compliance
FCA Civil Penalties Increased by the Department of Justice Again
The Department of Justice announced on February 3, 2017, that penalties for the False Claims Act (FCA) will be increasing once again, ...
Aggregate Spend Reporting
New Transparency Reporting Obligations Enacted by the Belgian Government
The government of Belgium enacted new legislation governing transparency reporting on December 27, 2016. The new legislation is known as The...
Life Sciences Compliance
Shire Settles Kickback Allegations with $350 Million
Shire Pharmaceuticals, an Ireland-based global specialty biopharmaceutical company, has agreed to pay $350 million to settle allegations o...
Life Sciences Compliance
A Pharmaceutical Company’s Offices in Athens Were Raided by Prosecutors
Swiss drug maker Novartis is in trouble as its offices in Athens were raided by corruption prosecutors a few days ago. The raid was part o...
Life Sciences Compliance
How the U.S. Department of Justice Recovered $4.7 Billion in 2016?
The United States Department of Justice made an annual announcement on December 14, 2016 in which the amount of money that was recovered i...
Life Sciences Compliance
How EU Member Counties Are Approaching the Issue of Consent Under Data Protection Laws
Although physician consent requirements are widespread across Europe, the fact is that different EU member countries have different rules su...
Life Sciences Compliance
Execs & Physicians at Doc-Owned Hospital Chain Indicted in Alleged Kickback Scheme
Law enforcement authorities have indicted executives and physicians affiliated with the physician-owned Forest Park Medical Center for alleg...
Data Driven Compliance
Highlights of the 3rd Annual Global Compliance Congress for Life Sciences
The 3 rd Annual Global Compliance Congress for Life Sciences was held by the CBI at the Hilton London Olympia on the 16 th & 17 th o...
consent management, EFPIA, Pharma Compliance, Physician Engagement
Challenges in Seeking HCP/O Consent Under the Data Protection Laws of The EU
For most pharma companies in the EU, seeking the consent of the HCP's/HCO's that they indulge in transactions is the most appropriate means ...
Aggregate Spend Reporting
Sunshine Act Reporting Challenges & How to Tackle Them
As the reporting date under the US Sunshine Act approaches, compliance teams are working harder than ever to collect spend records and h...
Data Driven Compliance
Highlights of the 17th Annual Pharma and Medical Device Compliance Congress
The 17th Annual Pharma and Medical Device Compliance Congress was held at the Mandarin Hotel in Washington, D.C from the 19 th to the 21 s...
EFPIA, Events, Pharma Commerical, Pharma Compliance, Physician Engagement
Highlights of the 4th Annual Pharma Compliance Europe Congress
The 4th Annual Pharma Compliance Europe Congress was held at the Royal Garden Hotel, London, UK, on the 5th and 6th of October, 2016. The co...
HCP Engagement
This Company Paid $28.1 Million for Violating The Anti-kickback Statute and False Claims Act
The largest nursing home pharmacy in the United States of America, based on the number of beds served, Omnicare, has agreed to pay $28.1 mi...
Fraud and Abuse Law
$513 Million Penalty Imposed on a Hospital for Illegal Patient Referral Payments
A major hospital chain in the U.S., Tenet Healthcare Corporation, along with two of its Atlanta-area subsidiaries, will pay more than $513 ...
Data Driven Compliance
17th Annual Pharma and Medical Device Compliance Congress
The Seventeenth Annual Pharma and Medical Device Compliance Congress is being held from the 19 th to the 21st of October, 2016, at the Mand...
Aggregate Spend Reporting
EFPIA Transparency Directive: What to Expect in The Future?
Three years after the initiation of the EFPIA code, member companies published their transfers of value for the first time in 2016 in order ...
Aggregate Spend Reporting
EFPIA Transparency Directive: What Should A Transparency System be Based On?
The EFPIA Transparency Directive deems it necessary for all member associations within the EU to publish spend data by Pharma manufacturers ...
Data Driven Compliance
4th Annual Pharma Compliance Europe Congress
The 4 th Annual Pharma Compliance Europe Congress is being held at the Royal Garden Hotel, London, UK, on October 5 th & 6 th , 2016. ...
CMS
DOJ and CMS Increasing Focus on Health Care Fraud
In the past couple of years, law enforcement agencies have recovered billions of dollars through judgments and settlements related to health...
HCP Engagement
Indictment of Novartis Korea Executives Over Rebates
Prosecutors have indicted six executives from the South Korean unit of Novartis for paying rebates to doctors so they may prescribe the comp...
Aggregate Spend Reporting
Highlights of 10th Annual Forum on Transparency & Aggregate Spend
CBI held the 10 th Annual Forum on Transparency and Aggregate Spend at the Ritz-Carlton in Washington, D.C. from 15 th – 17 th August,...
Aggregate Spend Reporting
Understanding the Sunshine Act and Open Payments
The relationship between the life sciences industry and healthcare professionals is complex, involving various financial transactions that c...
HCP Engagement
Medical Device Manufacturer: Fined $646M FOR Paying Kickbacks to Hospitals
In the first quarter of the year, Olympus Corp., the United States’ largest distributor of endoscopes and related equipment, agreed to pay ...
DOJ
DOJ Doubles FCA Penalties for Life Sciences Companies
The U.S. Department of Justice (DOJ) doubled the penalties for False Claims Act (FCA) violations on the 1 st of August, 2016. As of Aug...
Aggregate Spend Reporting
Off Label Spending - Using Transparency Data to Sniff Out Clues
Since 2013, Federal regulators have stepped up scrutiny of the relationships between pharmaceutical manufacturers and healthcare providers. ...
Data Driven Compliance
Next Generation Compliance: Using Analytics to Reduce Compliance Risks
Government agencies are increasingly using publicly available data sets in support of their allegations against pharmaceutical and device ma...

Ready to strengthen your compliance program?

Talk to our team to see how qordata can help your organization reduce risk and drive efficiency.

Get in Touch
(609) 375-0010
sales@qordata.com
103 Carnegie Center Dr, Suite 300
Princeton, NJ 08540

Company

  • About Us
  • Leadership Team
  • Our Partners
  • Contact Us
  • Careers

Products

  • Reporting
  • Transparency Reporting Solution
  • Monitoring
  • Compliance Central
  • Expense Monitoring & Auditing Solution (EMA)
  • Engagement
  • EngageAgent
  • Grants & Sponsorship Management Solution

Services

  • Compliance Program Setup
  • Customer Advisory Services
  • HCP Fair Market Value
  • Legal Services
  • Live Monitoring Checklists
  • Monitoring Plan Services

Thought Leadership

  • Surveys & Insights
  • Whitepapers
  • Webinars
  • Case Studies
  • Blogs

Your usage of this site constitutes acceptance of our Terms of Use & Data Policy. The material on this site may not be reproduced, distributed, transmitted, cached, or otherwise used without qordata's consent. qordata is an Equal Opportunity Employer — all qualified applicants will receive consideration without regard to race, gender, color, age, religion, national origin, veteran status, or any other protected characteristic.

PK Office  ·  NJ Office

© qordata 2026. All rights reserved. | Sitemap | Privacy Policy | Terms of Use
We use cookies We use cookies to enhance your browsing experience, personalise content, and analyse traffic. You can accept all cookies or manage your preferences.

Customize Consent Preferences

We use cookies to enhance your browsing experience, serve personalised content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. You can manage your preferences below.

Strictly Necessary Cookies Always Active
These cookies are essential for the website to function properly. They enable core features such as security, network management, and accessibility. You may not disable these.
Analytics & Performance Cookies
These cookies help us understand how visitors interact with our website by collecting and reporting information anonymously.
Functional Cookies
These cookies enable personalised features and functionality, such as remembering your preferences and language settings.
Targeting & Advertising Cookies
These cookies are used to deliver advertisements more relevant to you and your interests.
0
Skip to Content
qordata Inc.
qordata Inc.